PA-915 molecule shows long-lasting antidepressant effects without common side effects in mice

Depression and anxiety disorders are among the most widespread mental health disorders, with estimates suggesting that they ...
Medscape

Novel SNRI Promising for Major Depression: Phase 2 Data

A phase 2 trial suggests that the novel SNRI ammoxetine may effectively treat major depressive disorder while avoiding some side effects common to other antidepressants.